Skip to main content

Table 1 Characteristics of smokers participating in a hospital-initiated cessation program

From: Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program

 

Participants who censored (n = 957)

Participants for analysis (n = 1943)

6-month smoking abstinence

Success (n = 778)

Failure (n = 1165)

P

Age (years)

   

 < 0.001

  < 65

789 (82.4)

556 (71.5)

981 (84.2)

  ≥ 65

168 (17.6)

222 (28.5)

184 (15.8)

Sex

   

0.237

 Male

886 (92.6)

716 (92.0)

1054 (90.5)

 Female

71 (7.4)

62 (8.0)

111 (9.5)

Comorbiditiesa

   

 < 0.001

  < 2

631 (65.9)

405 (52.1)

729 (62.6)

  ≥ 2

326 (34.1)

373 (47.9)

436 (37.5)

Daily cigarette smoking

   

0.011

  ≤ 20

275 (28.7)

311 (40.0)

400 (34.3)

  > 20

551 (57.6)

467 (60.0)

765 (65.7)

 Missing

131 (13.7)

0 (0.0)

0 (0.0)

FTND

   

 < 0.001

  < 4

90 (9.4)

109 (14.0)

82 (7.0)

 4 to 6

472 (49.3)

411 (52.8)

527 (45.2)

  ≥ 7

395 (41.3)

258 (33.2)

556 (47.7)

Motivation

   

0.769

 Self-motivated

326 (34.1)

207 (26.6)

303 (26.0)

 Not self-motivated

631 (65.9)

571 (73.4)

862 (74.0)

Discharge diagnosis

   

 < 0.001

 Cancer

195 (20.4)

157 (20.2)

158 (13.6)

 CAD/HF

165 (17.2)

212 (27.3)

207 (17.8)

 COPD/pneumonia

22 (2.3)

37 (4.8)

40 (3.4)

 Others

575 (60.1)

372 (47.8)

760 (65.2)

ICU admission

   

 < 0.001

 Yes

213 (22.3)

251 (32.3)

156 (13.4)

 No

744 (77.7)

527 (67.7)

1009 (86.6)

Hospitalization

   

 < 0.001

  ≤ 4 days

456 (47.6)

336 (43.2)

637 (54.7)

  > 4 days

501 (52.4)

442 (56.8)

528 (45.3)

Cessation medications

   

0.175

 No use

823 (86.0)

673 (86.5)

1020 (87.6)

 NRT

75 (7.8)

56 (7.2)

81 (7.0)

 Non-NRT

22 (2.3)

31 (4.0)

28 (2.4)

 NRT and non-NRT

37 (3.9)

18 (2.3)

36 (3.1)

Number of in-hospital counseling

   

0.001

 1

773 (80.8)

616 (79.2)

995 (85.4)

 2

113 (11.8)

104 (13.4)

117 (10.0)

  ≥ 3

71 (7.4)

58 (7.5)

53 (4.6)

  1. CAD coronary artery disease, COPD chronic obstructive pulmonary disease, FTND Fagerstrom test for nicotine dependence, HF heart failure, ICU intensive care unit, NRT nicotine replacement therapy
  2. aComorbidities include cardiovascular disease, cancer, cerebral vascular disease, diabetes mellitus, hypertension, liver disease, respiratory system disease, and renal disease